Ocular surface inflammation is regulated by innate immunity
Authors:
- Mayumi UetaMUMayumi Ueta
- Shigeru KinoshitaSKShigeru Kinoshita
- 1 November 2012
- journal article
- review article
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 31 (6) , 551-575
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Prostaglandin E Receptor Subtype EP3 Expression in Human Conjunctival Epithelium and Its Changes in Various Ocular Surface DisordersPLOS ONE, 2011
- Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cellsExperimental Eye Research, 2011
- Detecting gene–gene interactions that underlie human diseasesNature Reviews Genetics, 2009
- The roles of TLRs, RLRs and NLRs in pathogen recognitionInternational Immunology, 2009
- Lack of MD‐2 expression in human corneal epithelial cells is an underlying mechanism of lipopolysaccharide (LPS) unresponsivenessImmunology & Cell Biology, 2008
- TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory eventsJournal of Experimental Medicine, 2008
- Association of Combined IL-13/IL-4R Signaling Pathway Gene Polymorphism with Stevens-Johnson Syndrome Accompanied by Ocular Surface ComplicationsInvestigative Ophthalmology & Visual Science, 2008
- Modulation of Corneal Epithelial Innate Immune Response to Pseudomonas Infection by Flagellin PretreatmentInvestigative Ophthalmology & Visual Science, 2007
- Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndromeBritish Journal of Ophthalmology, 2007
- IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon inductionNature Immunology, 2005